6th Cir. Asks Trial Court to Determine Whether Mylan Fentanyl Patch is ‘Drug’ or ‘Combination Product’
January 23, 2014
DOCUMENTS
- Opinion
DETROIT — A 6th Circuit U.S. Court of Appeals majority has reversed dismissal and remanded a Mylan fentanyl patch case for a determination of whether the patch is a “drug,” “device” or “combination product” under federal law.
In a Jan. 21 opinion, the majority explained that if the patch is considered a “drug” approved by the Food and Drug Administration, Mylan would be shielded from liability. If the patch is better defined as a "combination product," Mylan is not immune from suit in Michigan, the majority noted.
Beth Ann Miller sued Mylan Inc., Mylan Pharmaceuticals Inc. and Mylan Technologies …
FIRM NAMES
- Ishbia & Gagleard
- Pietragallo Gordon Alfano
UPCOMING CONFERENCES
![](https://harrismartin.s3.amazonaws.com/media/CACHE/images/uploads/conferences/iStock-115753557_fLooJhx/ebadaa70c9ae4eba2f27c08bcd68c09c.jpg)
HarrisMartin's Midwest Asbestos Litigation Conference
September 27, 2024 - St. Louis, MO
Four Seasons Hotel, St. Louis
![](https://harrismartin.s3.amazonaws.com/media/CACHE/images/uploads/conferences/iStock-1191161494_wqZG9UX/0b903ab949806641ed5433861fdab9cd.jpg)
HarrisMartin's Data Breach Litigation Conference
September 25, 2024 - Nashville, TN
Hutton Hotel in Lyric Ballroom C